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Cardiovascular diseases are the principal cause of death worldwide. The potentially
serious adverse effects of therapeutic drugs lead to growing awareness of the role
of Chinese herbal medicine in the treatment of cardiovascular diseases. Chinese
herbal medicine has been widely used in many countries especially in China from
antiquity; however, the mechanisms by which herbal medicine acts in the prevention
and treatment of cardiovascular diseases are far from clear. In this review, we briefly
describe the characteristics of Chinese herbal medicine by comparing with western
medicine. Then we summarize the formulae and herbs/natural products applied in the
clinic and animal studies being sorted according to the specific cardiovascular diseases.
Most importantly, we elaborate the existing investigations into mechanisms by which
herbal compounds act at the cellular levels, including vascular smooth muscle cells,
endothelial cells, cardiomyocytes and immune cells. Future research should focus on
well-designed clinic trial, in-depth mechanic study, investigations on side effects of herbs
and drug interactions. Studies on developing new agents with effectiveness and safety
from traditional Chinese medicine is a promising way for prevention and treatment of
patients with cardiovascular diseases.
Keywords: Chinese herbal medicine, hypertension, atherosclerosis, dyslipidemia, heart disease, cardiovascular
diseases
Cardiovascular diseases, mainly including atherosclerosis, hypertension, cardiac hypertrophy,
myocardial infarction and heart failure, are the principal cause of death worldwide. The increasing
number of patients around the world suffering from CVDs indicates the need for innovative
strategies for more effective prevention and treatment. Currently, western medicine, CHM and
integrative medicine are the three major models of health care around the world. The western
medicine has been considered as the mainstream medical treatment. For example, antithrombotic
drugs combined with timely reperfusion therapy, coronary artery bypass grafting or precutaneous
coronary intervention are widely applied to patients with CVDs. Although a widespread proof
Abbreviations: ANP, atrial natriuretic peptide; BP, blood pressure; BKCa, channel Ca2+-activated K+ channel; CHM,
Chinese herbal medicine; CVDs, cardiovascular diseases; ECM, extracellular matrix; (e)NOS, (endothelium) nitric oxide
synthase; HDL-C, high-density lipoprotein cholesterol; HO, heme oxygenase; HUVEC, human umbilical vein endothelial
cells; IL, interleukin; KATP, ATP-sensitive potassium; KRGE, Korean Red Ginseng extract; LDL, low-density lipoprotein;
LDL-C, low-density lipoprotein cholesterol; NO, nitric oxide; PPARα, peroxisome proliferator-activated receptor-alpha; ROS,
reactive oxygen species; Sal, salvianolic acid; SHR, spontaneous hypertension rats; SOD, superoxide dismutase; TC, total
cholesterol; TG, triglyceride; VSMCs, vascular smooth muscle cells.
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showed these therapeutic regimes effective in reducing
cardiovascular events, the potentially serious adverse effects
are still key challenges. Thus it prompted the search for
alternative and complementary therapies for better management
of CVDs. CHM generally applies some natural plant products
including dietary factors or herbal medicines. There is growing
awareness of the role of herbs in the prevention of CVDs and
the possibility of their use in treatment (Li et al., 2015). With the
more successful clinic application of CHM in CVDs prevention
and treatment, the effects of CHM have drawn greater attention,
even in developed countries including the United States and
Australia. In this review, we focus on both the clinic practices
and experimental studies to summarize the application of plant
products and mechanistic investigations.
SEARCH STRATEGY
To review all studies directly describing the application of CHM
in CVDs, we used the keywords “cardiovascular” and “herbs”
with limiting the search to title and/or abstract. The initial search
generated 281 results. We then afterward selected the articles
based on our aims. Since there are lots of formulae widely used
in clinic in China, Guidelines for Diagnosis and Treatment of
Common Internal Diseases in Chinese Medicine was referred
too. A total of 123 articles and 1 Chinese Guideline was finally
included in the review.
COMPARISON BETWEEN CHM AND
WESTERN MEDICINE
Chinese herbal medicine is characterized by “Holistic regulation,”
in which the organism is considered as a whole. With the
equilibrium of the human body as the guidelines, practitioners
of CHM pay more attention to the diseased patients rather than
the suffered diseases itself. Particular western medicine always has
a strong effect on a specific disease with focusing on a specific
physiological target and ignoring the specific characteristics of
each patient.
“Syndrome Differentiation based treatment” is another feature
of traditional Chinese medicine, which means diagnosis and
treatment based on an overall analysis of the illness and
practitioners timely modify formulae in accordance with the
varying syndromes and clinical manifestations. Thus, it is an
individualized treatment for different patients even with the
same disease. Particular western medicine usually works against
a specific pathological process of diseases rather than a patient.
Many CHM and foods originate from the same source and the
feature of “Homology of medicine and food” reflects that CHM
has few adverse effects. Traditionally, some foods are preferred
to drugs for health care, and certain kinds of herbs are regarded
as foods. Hawthorn fruit and garlic are such examples. However,
due to the strong pertinence, western medicine will inevitably
cause side effects. Although the efficacy of CHM is not as strong
as chemicals on a pathological process of CVDs, the feature of
individualized intervention with minimum adverse effects makes
CHM would be a good choice and will continue to make great
contributions to the health of CVDs patients.
APPLICATION OF CHM IN CVDs
Many experimental studies indicate that a great many herbs have
potential benefits for CVDs. Herbal plant-based formulations or
drugs are pivotal to traditional practices and application of plant
products as CHM treatment has been widely used in patients with
hypertension, atherosclerosis, congestive heart failure, angina
pectoris and other cardiovascular risk factors.
Application of Plant Products in
Hypertension
Hypertension is a worldwide health problem with high morbidity
and a major player in the onset of diseases such as atherosclerosis,
stoke, peripheral artery disease, heart failure and coronary artery
disease. Hypertension is defined as having a systolic BP of
≥140 mmHg and a diastolic BP of ≥90 mmHg. Every 20/10
(systolic BP/diastolic BP) mmHg increase indicates a higher risk
stage of hypertension, stage 1 (140–159/90–99 mmHg) and stage
2 (≥160/100 mmHg) with the latter stage requiring immediate
medical attention.
Notably, there are some formulae, many well known herbal
products and their extracts or secondary metabolites of the
herbs and spices exhibit antihypertensive effects. Interestingly,
in a population-based database enrolling 984 CHM users and
2434 non-CHM users with hypertension among type 2 diabetes
patients, the CHM users were characterized with slightly longer
duration time from diabetes to hypertension, suggesting that
CHM may restrain hypertension pathogenesis among type 2
diabetes patients (Lin et al., 2015). Here, we present the most
commonly used formulae and a comprehensive alphabetical
list of plant products with evidence suggesting beneficial in
hypertension therapy.
Formulae
Yiqi Huaju Formula and Bushen Qinggan Formula are regularly
applied in clinical practice for treating hypertension. Yiqi
Huaju Formula consists of Gastrodia elata, Uncaria, Eucommia
bark, radix Scutellariae, and bitter butyl tea. In a study with
43 hypertensive patients coupled with metabolic syndrome,
12 weeks of additional use of Yiqi Huaju Formula (together
with anti-hypertensive drugs) significantly decreased systolic
BP and 24-h BP variability compared with the control group
(anti-hypertensive drugs plus placebo), indicating that Yiqi
Huaju treatment may be better than antihypertensive drugs
alone (Chen et al., 2013). Bushen Qinggan Formula consists of
Astragali Mongholici, Rhizoma Coptidis, Pollen Typhae, Rhizoma
Alismatis, and Artemisiae Capillaries. A favorable effect of Bushen
Qinggan Formula was observed on control of BP variability
level after 8 weeks of treatment in a randomized controlled
pilot clinical trial (150 patients with hypertension). This was
accompanied with decreased endothelin and elevated nitric oxide
(NO)/endothelin in circulation, indicating improved endothelial
function (Wu et al., 2014). In addition, according to the
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TABLE 1 | Formulae for hypertension based on syndrome differentiation.
Symptom analysis Therapeutic principle Formulae Ingredients Chinese patent drug
Gan Huo Shang Yan Qing Gan Xie Huo Long-Dan-Xie-Gan Tang Longdancao, Chaihu, Zexie, Cheqianzi,
Sheng Dihuang, Danggui, Zhizi,
Huangqin, Gancao.
Xie Qing Wan, Dang Gui
Long Hui Wan
Tan Shi Nei Zu Hua Tan Qi Shi, He Wei Jiang Zhuo Ban-Xia-Bai-Shu-Tian-Ma
Tang
Banxia, Baishu, Tianma, Chenpi, Fuling,
Gancao, Gouteng, Zhenzhumu, Yujin.
Xuan Yun Ning Tablet
Yu Xue Nei Zu Huo Xue Hua Yu Tong-Qiao-Huo-Xue Tang Dilong, Danggui, Chuanqiong, Chishao,
Taoren, Honghua, Baizhi, Shichangpu,
Laocong, Quanxie
Xin Mai Tong Tablet, Xin An
Ning Tablet
Yin Xu Yang Kang Ping Gan Qian Yang, Qing Huo Xi Feng Tian-Ma-Gou-Teng Yin Tianma, Gouteng, Shijueming, Niuqi,
Duzhong, Sangjisheng, Huangqin,
Zhizi, Fushen, Yejiaoteng, Yimucao
Qing Nao Jiang Ya Tablet,
Nao Li Qing Capsule
Shen Jing Bu Zu Zi Yang Gan Shen, Yi Jing Tian Sui Zuo-Gui Wan Shu Dihuang, Shanzhuyu, Shanyao,
Guijia, Lujiaojiao, Gouqizi, Tusizi, Niuqi
Jian Nao Bu Shen Wan, Yi
Ling Jing
Qi Xue Liang Xu Bu Yi Qi Xue, Tiao Yang Xin Pi Gui-Pi Tang Dangshen, Baishu, Huangqi, Danggui,
Longyanrou, Dazao, Fushen, Yuanzhi,
Suanzaoren
N/A
Chong Ren Shi Tiao Tiao She Chong Ren Er-Xian Tang Xianmao, Xianlingpi, Danggui, Bajitian,
Huangbai, Zhimu, Baishao, Danshen,
Yimucao, Cheqianzi.
Lu Gui Bu Shen Capsule
Formulae should be modified according to specific syndromes and clinical manifestations.
Guidelines for Diagnosis and Treatment of Common Internal
Diseases in Chinese Medicine, there are some frequently used
formulae for hypertension in clinic which are based on syndrome
differentiation (China Association of Chinese Medicine, 2008).
The formulae are listed in Table 1.
Natural Plant Products
Allium sativum L (Amaryllidaceae)
Allium sativum L is also called garlic. It receives emerging
interest from pharmacologists and health practitioners with its
multi therapeutic effects, including hypotensive capacity, anti-
inflammatory, antioxidant, antibacterial and hypocholesteremic
properties. Among the garlic’s organo-sulfur constituents, allicin
is the most responsible one. Fresh garlic directly releases allicin
while chewing, whereas dried garlic preparations lack allicin but
contain both allinin and allinase which could convert allinin to
allicin. Evidence from many investigations and meta-analysis of
randomized, controlled trials concluded that garlic supplements
induce significant reduction in mean arterial pressure, drop
in either systolic BP or diastolic BP with different extent.
Interestingly, some studies indicate that aged garlic extract
produces consistent lowering of BP compared to other forms of
garlic (Blesken, 1992). However, more experiments are needed to
confirm garlic’s effect on hypertension since some studies come
with no conclusive result (Shao et al., 2016). Despite having these
multifarious effects, garlic also produces a few minor side effects,
including abdominal swelling, heartburn, flatulence, and acid
reflux et al.
Andrographis paniculata (Acanthaceae)
Andrographis paniculata is a plant that is commonly known
as the King of Bitter. Several hypotensive labdane-type
diterpenoid compounds, andrographolide, 14-deoxy- 11,12-
didehydroandrographolide and 14-deoxyandrographolide
have been identified in Andrographis paniculata extracts.
Animal studies show that treatment with its extracts decrease
angiotensin converting enzyme and ROS activities in SHRs
leading to decrease in BP (Zhang and Tan, 1996). Ex vivo studies
demonstrate that the extracts reduce vascular resistance reflected
by decreased coronary perfusion pressure in rat isolated hearts
(Awang et al., 2012). However, no clinic trials have yet been
conducted using the King of bitter.
Apium graveolens L (Apiaceae)
Apium graveolens L is also known as celery. The hypotensive
effect of celery has been reported in in vivo animal studies.
The extracts of celery reduce BP in deoxycorticosterone acetate-
induced hypertensive rats or animal model of SHR (Moghadam
et al., 2013). Importantly, extracts and constituents of celery have
been reported to lower arterial pressure in humans, possibly
by lowering levels of circulating catecholamines and decreasing
vascular resistance (Houston, 2005).
Bidens pilosa L (Compositae)
Bidens pilosa L is also called Beggar’s Tick. It is native to America
and belongs to the family Compositae. Extracts of its leaves were
able to prevent and attenuate high BP in different hypertensive
rat models, both SHR and fructose-fed hypertensive rats (Steiner
et al., 1996). In fructose-fed rats, 75 and 150 mg/kg of methanolic
leaf extract of B. pilosa, showed both therapeutic and preventative
effect on systolic BP (Steiner et al., 1996). However, clinical trials
are required to determine the potential effect of this plant on
hypertension.
Camellia sinensis (Theaceae)
Camellia sinensis, also known as tea, is most frequently
consumed and only second to water. Its cardiovascular
protective effect is well known worldwide. Catechins, the major
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flavonoids in tea, include (–)- epicatechin, (–)-epicatechin-
3-gallate, (–)- epigallocatechin, and (–)-epigallocatechin-3-
gallate. (–)-epigallocatechin-3-gallate constitutes the primary
component of tea’s total catechins. Although some trials come to
conclusion of no change in BP subsequent to drinking tea, lots
of studies suggest that tea consumption reduces both systolic BP
and diastolic BP by ∼2 mmHg each. Interestingly, the green tea
evokes a more powerful hypotensive effect compared to black tea.
Coptis chinensis (Ranunculaceae)
It’s commonly known as goldthread and widely used in
Chinese folk medicine. The goldthread and its main component
berberine, have the ability to lower BP. Indeed, a recent meta-
analysis of twenty-seven randomized controlled trials involving
2569 patients reported that berberine can cause a significant
hypotensive effect (Lan et al., 2015). In addition, this meta-
analysis concluded that combined with an oral hypotensor,
berberine can significantly reduce BP more than the hypotensor
alone can do. The magnitude of the decrease was at an average
of 4.91 and 2 mmHg for systolic BP and diastolic BP, respectively
(Lan et al., 2015).
Crataegus spp. (Rosaceae)
It is also known as Hawthorn or Shanzha. The plants are shrubs
that belong to a genus comprising almost 300 species and have
been used in traditional medicine for treatment of CVDs since
the seventeenth century. Hawthorn is used to dissipate food
accumulation, to improve blood circulation, and to disperse
blood stasis. The antihypertensive actions should be credited
to the plant’s multiple components: flavonoids (hyperoside,
quercetin, rutin, and vitexin) and oligomeric proanthocyanidins
(OPCs, epicatechin, procyanidin, and procyanidin B-2). Modest
decreases in BP have been observed in a few human-based studies
with a demographic of hypertensive patients (Walker et al., 2002;
Tassell et al., 2010). In a randomized, double-blind, placebo-
controlled study where mildly hypertensive subjects were treated
with 500 mg of hawthorn extract for 10 weeks, a promising
tendency for a reduction in diastolic BP was reported (Walker
et al., 2002). In another clinic study, administration of hydro-
alcoholic extracts of hawthorn flowers to hypertensive patients
(age range 40–60 years) for 3 months induced a decrease in
both systolic BP and diastolic BP by around 13 and 8 mmHg,
respectively (Asgary et al., 2004).
Crocus sativus L (Iridaceae)
Crocus sativus L, also known as Saffron, a plant indigenous to
Southwest Asia, Spain, Greece, and Morocco, is a stemless herb.
Saffron’s main components include crocin, picrocrocin, safranal,
and crocetin. Several reports support the use of saffron for anti-
hypertensive benefits. A clinical study reports that 400 mg of
Saffron tablets administered for 7 days are able to significantly
reduce the systolic BP and mean arterial pressure in healthy
humans by 11 and 5 mmHg, respectively (Modaghegh et al.,
2008). Six weeks old stroke-prone SHRs are given crocetin for
3 weeks and this treatment significantly moderates the increase in
systolic BP observed with age (Higashino et al., 2014). Saffron also
demonstrates vasorelaxant activities in different animal models,
including male Sprague-Dawley rats (Fatehi et al., 2003), stroke-
prone SHRs (Higashino et al., 2014), deoxycorticosterone acetate-
salt induced hypertensive male Wistar rats (Imenshahidi et al.,
2010) but not normotensive rats (Imenshahidi et al., 2015).
Hibiscus sabdariffa L (Malvaceae)
Also known as Roselle, Hibiscus sabdariffa is widely used for
hypertension, fever, and other diseases in folk medicine. Different
parts of this plant (buds, calyx, flowers, leaves, and petals—
fresh or dried) are used for health purposes and as refreshing
beverages, food items (jams, preserves), or lotions. Hibiscus’s
effects of hypotension have been extensively investigated in both
animal and human studies (McKay et al., 2010; Ojeda et al.,
2010; Inuwa et al., 2012). The blood lowering effects were
notable subsequent to treatment with dried extract of Roselle
calyx for 4 weeks in patients with stage 1 or 2 hypertension
(Herrera-Arellano et al., 2007). In addition, consuming Roselle’s
tea (240 ml—three times a day for 6 weeks) significantly reduces
systolic BP, diastolic BP, and mean arterial pressure by 7.2,
3.1, and 4.5 mmHg, respectively in mild and pre-hypertensive
patients (65 subjects, age range 30–70 years old) (McKay et al.,
2010), supporting Hibiscus’ therapeutic role in ameliorating
hypertension.
Hippophae rhamnoides L (Elaegnaceae)
Hippophae rhamnoides L is also called Saji or Sea buckthorn
and its dry fruits are used in China as an herbal medicine.
Analysis showed that the powder made of dry hippophae fruits
contains the vitamins C, B1, B2 and E, provitamin A, rutin,
serotonin, cytosterol, selenium and zinc. The stroke-prone SHR
were fed ad libitum with blocks of rat chow supplemented with
Hippophae powder and the effect of lowering BP was examined.
The mean arterial BP and heart rate were significantly decreased
by the Hippophae treatment (Koyama et al., 2009), which is in
accord with previous studies showing that Hippophae extracts
decreased intracellular Ca2+ in cultured VSMCs (Zhu et al.,
2005).
Nigella sativa L (Ranunculaceae)
Nigella sativa L, also known as Black Cumin or Habbatul barakah
(seed of blessing), has been used in the kitchens of Europe,
the Middle East, Africa, and Asia for centuries. Thymoquinone,
one of the most abundant and bioactive components, has
been identified as the major element in its healing effects.
Similar to other herbs, N. sativa and its constituents have been
shown to reduce BP in humans and different animal models
of hypertension. N. sativa’s seed extract administrated orally
(either 100 or 200 mg, two times per 24 h for 8 weeks) to
mild hypertensive male patients recorded a dose-dependent fall
in both systolic BP and diastolic BP (Ried, 2016). Again, in
a randomized, placebo-controlled, double-blind study with 70
healthy subjects, N. sativa oil caused a significant decrease of
10.6 mmHg in systolic BP and 9.6 mmHg in diastolic BP (Fallah
Huseini et al., 2013).
Panax ginseng C.A. Mey (Araliaceae)
Panax ginseng, also called Panax or Renshen, has been used
in folk medicine for several centuries. Ginseng is prepared
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and administered in various forms, either as a solid: tablets,
capsules, dried roots; or as a liquid: oil, extracts or tea.
There are four most common species of Ginseng, including
P. ginseng (Asian or Korean Ginseng), P. quinquefolius
(American Ginseng), P. japonicas (Japanese Ginseng) and
P. notoginseng (Chinese Ginseng) are the four most common
species of ginseng. Heterogeneous triterpenoid saponins and
steroid glycosides or ginsenosides (or panaxosides) are the active
principle components of ginseng. Several clinical trials have been
conducted to assess the efficacy of ginseng in BP regulation.
Both Asian/Korean Ginseng extract and American Ginseng
caused a significant decrease in systolic BP and diastolic BP in
hypertensive patients (Mucalo et al., 2013; Rhee et al., 2014). The
mode of action may be related with antagonizing a calcium ion
channel in vascular tissues, which may result in lowering BP.
However, conflicting reports of elevated BP also exist (Jang et al.,
2011; Kim, 2012). For example, studies have shown that low doses
of ginseng raise BP, while higher concentrations are hypotensive
(Jang et al., 2011), which need more experiments to clarify the
differentiation.
Pueraria lobata (Willd) ohwi (Leguminosae)
It is also known as Kudzu root or Gegen. Kudzu root has
traditionally been used in Chinese medicine for treating
CVDs and Type II diabetes. It is a rich source of polyphenolic
compounds, including isoflavones, isoflavonoid glycosides,
coumarins, puerarols, but-2-enolides and their derivatives.
Puerarols attract more attention to investigate the direct effect on
BP. According to Wong’s review, the anti-hypertensive effect of
puerarin was shown as early as 1980s evidenced by reduced BP,
heart rate and plasma rennin activity in SHRs and this effect may
be exerted through blocking the effect of β-adrenergic receptors
(Wong et al., 2011). Verapamil is a positive control inhibiting
Angiotensin II type I receptor and angiotensin-converting
enzyme 2 in SHRs. Similar to it, puerarin treatment significantly
repressed the mRNA levels of Angiotensin II type I receptor
and angiotensin-converting enzyme 2 in cardiac tissues (Ye
et al., 2008). Further interdisciplinary collaboration to bridge
the gap between traditional medicine and modern biomedical
medicine is needed for the development of Kudzu root as an
effective medicine for the management of hypertension and
other CVDs.
Salviae miltiorrhizae (Lamiaceae)
It is also known as Danshen, or red/Chinese sage. Danshen
is one of the oldest and most frequently consumed Chinese
traditional herbs and is commonly used for the treatment of
CVDs. Sal A, Sal B, Danshensu, and tanshinones are its most
effective ingredients. A combination treatment of Danshen and
Gegen was shown to lower BP in SHRs and to induce relaxation
of several kinds of arteries including porcine coronary arteries,
rat aorta, and basilar arteries (Al Disi et al., 2015). Apart from
its vasodilatory capacity, Danshen expresses additional anti-
hypertensive parameters such as antioxidative, anti-proliferative,
and anti-inflammatory activities which will be discussed in
more details in Section “Mechanisms of Plant Products in the
Attenuation of CVDs.”
Scutellaria baicalensis Georgi (Lamiaceae)
The dried roots of S. baicalensis, also known as Huangqin
in China, have been widely employed in traditional CHM as
popular antibacterial and antiviral agents. Baicalein and its
glycoside, baicalin, are the major ingredients responsible for
its beneficial effects. Its BP lowering effect in dog and rat was
reported as early as 1980’s (Huang et al., 2005). However, the
baicalein exerts a complex effect on the agonist contracted
rat mesenteric arteries. Within a relative low concentration
range (0.3–10 µM), baicalein potentiates vasoconstricting
responses to phenylephrine, U46619, or to elevated extracellular
potassium in endothelium-intact artery rings (Chen et al.,
1999; Tsang et al., 2000), whilst it produces relaxations at
concentrations greater than 10 µM (Chen et al., 1999). Since
the increased vessel contraction is absent upon removal
of the endothelium while the relaxant effect of baicalein
remains (Chen et al., 1999), endothelium-derived vasoactive
factors may be involved in the bidirectional effect on vascular
function. To be specific, baicalein and baicalin increase the
evoked contractile responses likely through inhibition of
NO production and/or release in the endothelium (Huang
et al., 2000, 2002; Tsang et al., 2000). The mechanisms
by which baicalein lowers BP will be discussed in Section
“Regulating Calcium Levels in PKA/PKG/PKC-Dependent
Way.”
Application of Plant Products in
Atherosclerosis and Dyslipidemia
Atherosclerosis, one of the primary causes of CVDs, is a
vascular disease that occurs at susceptible sites in major
arteries. It is an inflammatory process and ultimately causes
stenosis or thrombosis with potentially lethal distal ischemia.
The main elements involved in the complex pathogenesis of
atherosclerosis include hyperlipidemia, endothelial injury, LDL
subendothelial retention and oxidation, monocyte migration
and activation, VSMC migration and proliferation, foam
cell formation, apoptosis and efferocytosis and unresolved
inflammation. Among them, dyslipidemia is the primary
independent risk factors, which is characterized by elevated
level of total cholesterol (TC), triglyceride (TG), LDL-C and by
lowered level of high-density lipoprotein cholesterol (HDL-C) in
serum.
The description of the clinical manifestations and treatment
of atherosclerosis can be found in the classic traditional Chinese
medicine book Inner Canon of yellow Emperor, as early as
500BC. Atherosclerosis, dyslipidemia and its resulting heart
disease have been treated with numerous herbal remedies for
centuries. Then, we present a comprehensive alphabetical list
of plant products which are most commonly used to attenuate
atherosclerosis and lower hyperlipidemia.
Allium fistulosum L (Amaryllidaceae)
Allium fistulosum L is widely cultivated in Southern China.
Treatment with Fistular onion stalk, the derivant from
A. fistulosum., induces a significant reduction in the average
lesion area of atherosclerosis and preservation of the vascular
wall and immune cell infiltration. The extract also reduces
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the levels of the inflammatory cytokines IL-1β, IL-6, MCP1
and TNFα and downregulated the local activity of the rennin-
angiotensin-aldosterone system in the aortic tissue. In addition,
extract treatment inhibits several local inflammatory signaling
pathways by preventing its activation, including phosphorylation
of the NFκB, Janus kinase/signal transducers and activators of
transcription and mitogen-activated protein kinase pathways
(He B. et al., 2014). These data indicate that fistular onion stalk
extract may be useful for the attenuation of atherosclerosis, and
the mechanism includes the regulation of the local inflammatory
responses.
Allium sativum L (Amaryllidaceae)
In addition to the anti-hypertensive effect, there is also wide
spread belief among general public that Allium sativum L
(garlic) has beneficial effects on dyslipidemia in patients. Seventy
type 2 diabetes patients with newly diagnosed dyslipidemia
were divided into two groups and were given tablet garlic
300 mg (containing 1.3% allicin) twice daily and identical
placebo tablets respectively. 12-week of garlic treatment induces
a significant reduction in TC and LDL-C, a significant increase
in HDL-C (Ashraf et al., 2005). In a double-blind, crossover
study of moderately hypercholesterolemic men, treatment with
7.2 g aged garlic extract induced a maximal decrease of
6.1% in serum TC levels and 4.6% in LDL cholesterol
levels (Steiner et al., 1996). These effects were Although one
recent meta-analysis concluded that garlic decreases TC to
a modest extent, an effect driven mostly by the modest
decreases in TG, with no appreciable effect on LDL or
HDL cholesterol (Reinhart et al., 2009), many studies suggest
garlic to be effective in improving lipid metabolism (Ried,
2016). Since some meta-analysis has been based on trials with
inadequate study designs, methodological deficiencies, the effect
of garlic on atherosclerosis and dyslipidemia awaits further
investigation.
Astragalus propinquus (Fabaceae)
The dried root of Astragalus propinquus, Radix Astragali, is also
known as Huangqi. Polysaccharides, flavonoids, and sponins
are the main active components of membranous milkvetch
root. Studies have shown that Huangqi extract significantly
decreased the area of atherosclerosis plaques (17.24% ± 4.22%
vs. 49.87% ± 9.37%, P < 0.01) and level of serum oxLDL
(5.2 ± 6.1 µg/ml vs. 15.8 ± 5.4 µg/ml, P < 0.01) in ApoE−/−
mice (You et al., 2012). Effects of its extract and components on
lipid profile are also summarized in a review, in which the serum
of TG, TC, and LDL-C levels were reduced by both Astragalus
mongholicus extracts treatment at 0.4 and 0.8% for 5 weeks and
polysaccharides from Astragalus administered at an oral dosage
of 40 mg, 100 mg/kg/day in hyperlipidemia rats for 40 days (Guo
et al., 2014). Accordingly, the HDL-C levels were increased by
these treatments (Guo et al., 2014).
Coptis chinensis Franch. (Ranunculaceae)
Rhizoma Coptidis, also known as Huanglian, is derived from
the dried root and rhizome of Coptis chinensis Franch., Coptis
deltoidea C. Y. Cheng et Hsiao, and Coptis teeta Wall. Its
main components include lignans and alkaloid, in which
berberine is the active component for lipid lowering. Because
of berberine’s active effect for lipid lowering, most of the
studies focus on this component. Studies have shown that
berberine administration significantly decreased the serum TG,
TC, LDL-C, when taken orally or injected intraperitoneally
(Zhou et al., 2008; Chang et al., 2012). In addition, Caucasian
obese human subjects were orally given 500 mg berberine, three
times a day for 12 weeks. The blood lipid was significantly
reduced and TG, TC were decreased by 23 and 12.2%,
respectively (Hu et al., 2012). In a meta-analysis, berberine
induced a significant reduction in these biomarkers in 874
participants in11 randomized controlled trials (Ma et al.,
2013).
Crataegus spp. (Rosaceae)
Known as hawthorn, its hypolipidemia effect has been
investigated widely in animal studies. In high-fat diets fed
mice, the oral administration of the whole extract at a
dosage of 250 mg/kg/day for 7 days induced blood lipid
decrement (Niu et al., 2011). Then, the specific effects of
aqueous and ethanol extracts of hawthorn on lipid profiles
were compared. In a high-fat emulsion fed mice, both ethanol
and aqueous extracts possessed hypolipidemia activities and
the ethanol extract exhibited more favorable effects than
the aqueous extract (Shao et al., 2016). This lipid lowering
effect of hawthorn mostly contributes to inhibition of the
progression of atherosclerosis which was evidenced by the
significantly inhibited pathological changes and reduced intima-
media thickness in the arteries (Zhang et al., 2013). In-depth
exploration demonstrated that the lipid-lowering action may
be due to the anti-inflammation activities, the upregulation
of PPARα to facilitate β-oxidation-related enzymes in liver
leading to lipid degradation, enhanced expression of hepatic
LDL receptors resulting in a greater influx of plasma cholesterol
into the liver, and the suppressed cholesterol biosynthesis and
increased degradation of cholesterol to bile acids (Niu et al.,
2011; Walden and Tomlinson, 2011; Zhang et al., 2013; Shao
et al., 2016). The hypolipidemic effects of hawthorn in clinic
remain further study.
Epimedium brevicornum Maxim (Berberidaceae)
Epimedium brevicornum Maxim, an important traditional
CHM, has been used widely for 1000s of years in China,
Korea, and Japan. Icariin, a flavonoid isolated from
Epimedium brevicornum Maxim, is considered as the
main pharmacological active constituent. In the high
cholesterol diet-induced atherosclerosis rats, the levels of
blood lipids including TC, TG, LDL-C, and malonaldehyde
were significantly increased, while HDL-C and SOD were
significantly decreased. Icariin succeeded in improving these
biochemical parameters toward the normal values (Hu et al.,
2016).
Fallopia multiflora Thunb. (Polygonaceae)
Its dried root tuber is Radix Polygoni Multiflori, also known
as Heshouwu. Raw and prepared pharmaceutical forms are
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frequently used. Guo et al. (2014) reviewed the hypolipidemic
effect of Heshouwu from some Chinese literature which
demonstrated that the total extract of the Radix Polygoni
Multiflori significantly reduced the serum levels of TC, TG and
LDL-C in hyperlipidemic rats when administered at an oral
dosage of 12 mg and 24 mg/kg/day for 4 weeks. Similarly,
these lipid profiles in the hyperlipidemic rats were lowered by
the treatment of the ethlacetate extracting fraction and stilbene
glycoside from the tube of Radix Polygonum Multiflorum too
(Guo et al., 2014).
Fermentum Rubrum (Aspergillaceae)
Fermentum Rubrum, popularly known asred yeast rice, is
the fermented product of Monascus purpureus on rice. It is
composed of 13 kinds of natural statins, unsaturated fatty
acids, ergosterol, amino acids, flavonoids, alkaloid, trace element,
and so forth. Some clinic studies have demonstrated the lipid
lowering effects of the red yeast rice. A twice daily dose of
red yeast rice at 600 mg for 8 weeks was found to reduce
LDL-C by 27.7%, TG by 21.5%, and TC by 15.8% (Lin
et al., 2005). Similar effects were observed in 72 patients
with idiopathic persistent nephritic syndrome with secondary
dyslipidemia (Gheith et al., 2008, 2009). Xuezhikang capsule
is the extract of red yeast rice. Scholars in China made a
systematic review on the clinical randomized controlled trials
for hyperlipidemia treatment with Xuezhikang, which included
a total of 6520 participants in 22 randomized trials. It was
concluded that Xuezhikang remarkably lowered TC, TG, and
LDL-C compared with the inositol nicotinate (Fallah Huseini
et al., 2013).
Olea europaea L. (Oleaceae)
The beneficial effects of Olea europaeal L., especially olive
leaf extract are known since antiquity, with numerous records
confirming its therapeutic use. According to the European
Pharmacopeia, the most abundant substances in standardized
dry leaf extracts are oleuropein, hydroxytyrosol, caffeic acid,
tyrosol, apigenin, and verbascoside, with oleuropein being
the major component of olive leaf extract. Olive leaf extract
treatment reduces the atherosclerostic lesions size and the
thickness of intima in atherosclerotic rabbits, accompanied
with decreased levels of atherosclerotic markers, including
serum TG, TC, LDL, HDL, and malonaldehyde with a parallel
downregulation of MCP1, vascular cell adhesion molecule-
1, NFkB and TNFα (Wang et al., 2008). Consistent with
it, another animal study showed that a 1-month intake of
hydroxytyrosol by rabbits consuming an atherogenic diet results
in a reduced size of atherosclerotic lesions compared to
control animals (Gonzalez-Santiago et al., 2006). However, the
results originating from in vivo models are divergent. The
intake of hydroxytyrosol in an in vivo apo-E knockout mice
model showed that this compound, when administered for
10 weeks, leads to atherosclerotic lesions associated with the
activation of monocytes and modification of the blood lipid
profile (Acin et al., 2006). These studies indicate that under
certain conditions the phenol could be rather harmful than
cytoprotective.
Panax ginseng C.A. Mey (Araliaceae)
The resources and components have been discussed in Section
“Application of Plant Products in Hypertension.” A serious
of studies has demonstrated the hypolipidemic effects of its
components. For example, the levels of plasma TC, TG, and
LDL-c in C57/BL-ApoE gene knockout hyperlipidemia rats were
reduced by intragastric administration of ginseng saponins at
an oral dosage of 2 mg/kg/day for 90 days. Ginseng saponin
is divided into Rb1, Rb2, RC, Rd, Re, and Rl. Ginseng saponin
Rb administered at an oral dosage of 50–200 mg/kg/day in
hyperlipidemia rat for 12 days significantly reduce the TG, TC,
and LDL-c levels in serum and liver (Yue et al., 2012). Ginseng
radix can be metabolized into compound k in small intestinal.
In vitro, the metabolites significantly activate the AMP-activated
protein kinase (AMPK) to affect the lipid metabolism in insulin-
resistant HepG2 human hepatoma cells (Kim et al., 2009).
Pueraria lobata (Willd) ohwi (Leguminosae)
Also known as Kudzu Root, its effects on hyperlipidemia are
investigated in a series of studies. Puerarin, the active component
significantly reduced the serum lipid concentration or hepatic
cholesterol levels in hyperlipidemia rats, when administrated
at oral dosages of 300 mg/kg/day for 4 weeks or injected
intraperitoneally at 50 mg/kg/day for 30 days (Yan et al., 2006).
Furthermore, hepatic lipid metabolism was also enhanced in
ovariectomized rats by oral administration of Kudzu root (Wang
et al., 2004).
Reynoutria japonica Houtt (Polygonaceae )
Reynoutria japonica Houtt is a synonym of Polygonum
cuspidatum siebold and Zucc. Its dried root and rhizome
is known as Huzhang in Chinese medicine. Polydatin and
resveratrol are the primary active components. It has been found
that oral administration of polydatin at dosages of 25 mg–
150 mg/kg/day for 15–21 days significantly decreased TC, TG,
and LDL-C levels or TC/HDL-C ratio in hyperlipidemic hamsters
or rabbits (Du et al., 2009; Xing et al., 2009). Intragastrical
administration of another component resveratrol at dosages
of 10–70 mg/kg/day for 6 weeks not only decreased levels of
serum lipid but also attenuated diet-induced hepatic steatosis and
atherosclerosis index in hyperlipidemic mouse (Xie et al., 2014).
Rheum palmatum Linn (Polygonaceae)
Rheum palmatum Linn., Rheum tanguticum Maxim. Ex Balf.,
or Rheum officinale Baill belongs to the family of Poygonaceae.
Radix Et. Rhizoma Rhei, also known as Dahuang or rhubarb, is
derived from the root and rhizome of Polygonaceae members.
The main active component includes rhein, aloe emodin,
emodin, chrysophanol, and physcion. There is a series of studies
exhibited the lipid-lowering effects in animals or patients. For
example, the decoction boiled from rhubarb at 8, 16, and
32 g/kg/day for 5 days caused fatty degeneration of the hepatic
cell in mice. Administration of the powders of rhubarb, at
5 g/day orally for 24 weeks, decreased serum TG and TC
levels in patients with diabetic nephropathy (Gao Q. et al.,
2010). Rhein, one of the active components or rhubarb, at an
oral dosage of 150 mg/kg/day for 12 weeks, was proved to
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be lowering serum TG, TC, and LDL-C levels in mice with
diabetic nephropathy. Thus the lipid-lowering effect of rhubarb,
at least, partially dues to the component rhein. Danthron is
another extract of rhubarb. It was observed that danthron dose-
dependently promoted the phosphorylation of AMPK and acetyl-
CoA carboxylase in both HepG2 and C2C12 cells. Meanwhile,
danthron significantly reduced sterol regulatory element-binding
protein 1c synthesis and fatty acid synthase gene expressions,
contributing to the inhibitory effect on lipid metabolism (Han
et al., 2013). However, some side-effects, including vomiting,
headache, diarrhea and abdominal pain, are reported by some
volunteers.
Salviae miltiorrhizae (Lamiaceae)
It has been described in Section “Application of Plant Products
in Hypertension.” It is widely used to treat patients with
coronary artery disease in China. Studies have showed decrement
in levels of TC, TG and LDL-C when administrated with
its aqueous extracts orally (50, 100, and 150 mg/kg/day for
4 weeks in hyperlipidemic rats) (Ji and Gong, 2008) or
intravenous injected with tanshinone IIA, the main component
(80 mg/day for 14 days in patients with diabetes) (Jang et al.,
2008).
Scutellaria baicalensis Georgi (Lamiaceae)
Scutellaria baicalensis, known as Huangqin, is derived from
the dried root of Scutellaria baicalensis Georgi. The most
effective lipid-lowering component is flavonoid compound. Both
stem-leaf total flavonoids administrated at oral dosages (25–
150 mg/kg/day) and 0.05% radix extract added to the diet
significantly reduced the serum TG, TC, and LDL-C levels
or increased HDL-C levels (Regulska-Ilow et al., 2004). In
addition, treatment with flavonoids from the Huangqin leaves
increased the activity of lecithin cholesterol acyltransferase in
hyperlipidemia rats (Regulska-Ilow et al., 2004), contributing to
the lipid-lowering effect.
Senna obtusifolia Linn. (Fabaceae) or Cassia tora
Linn. (Leguminosae)
The ripe seed of Senna obtusifolia Linn. (Fabaceae) or Cassia
tora Linn. (Leguminosae) is Semen Cassia, known as Juemingzi.
Anthraquinone glycosides are the active component. It has been
found that the extract from Semen Cassia at lower doses (8–
15 mg/kg/day) for 35 days, or at higher doses (180 mg/kg/day) for
7 days, significantly decreased TC, TG and LDL-C and increased
HDL-C in hyperlipidemic animal models. Similar results were
induced by administration with the total anthraquinone from
Semen Cassia for 2 months in alcohol treated SD rats (Guo et al.,
2014).
The Others
There are many other herbs which show the hypolipidemic
effects and widely used in Chinese medicine. These herbs
include Rhizoma (Chuanxiong), Rhizoma Curcumae Longae
(Jianghuang), Rhizoma Alismatis (Zexie), Semen Plantaginis
(Cheqianzi), and Folium Nelumbinis (Heye). The oral
administration of the extracts or the active components
exerts the hypolipidemic effects and improving lipid metabolism
(Guo et al., 2014). In addition, there are some formulae for
dyslipidemia which are applied in clinic basing on syndrome
differentiation (China Association of Chinese Medicine, 2008).
The formulae are listed in Table 2.
Application of Plant Products in Heart
Diseases
Cardiovascular diseases involving the heart includes angina,
myocardial infarction, cardiomyopathy, congenital heart disease,
and heart failure, etc. Some of the diseases interact on each
other or on other vascular diseases. For example, coronary
artery diseases involve atherosclerosis, which may be caused
by hypertension, hyperlipidemia, whereas heart failure can
arise as consequence of large myocardial infarctions. Thus,
herbs applied in treatment of hypertension, atherosclerosis
and lowering lipid profiles should contribute to attenuating
heart diseases too. Here, we present formulae and the natural
plants frequently used in clinic and lab studies in alphabetical
order.
Formulae
There are some formulae which are frequently used to treat
heart diseases. Chinese herbal formula Sini Tang/dicoction
(Aconitum carmichaelii, Zingiber officinale, Glycyrrhiza uralensis,
or/and Cinnamomum cassia) was reported to improve cardiac
function (ejection fraction and fractional shortening) after
myocardial infarction in rats. With 1H NMR and UHPLC-MS
measurement, 21-day application of Sini decoction effectively
reversed the urinary metabolic profiles in the myocardial
infarction rat model (Tan et al., 2012; Sheu et al., 2014). Another
formula consists of Terminalia arjuna, Cactus grandiflorous,
Crataegus oxyacantha, and Piper nigrum. Preadministration and
postadministration of this herbal mixture restore the levels of
biomarker of cardiotoxicity, including cardiac marker enzymes,
lipids profile, and antioxidant enzymes (Lin et al., 2011).
Rhodiola formulation is claimed to relieve the symptoms of
ischemic heart disease and improve the electrocardiography
in a number of clinical studies (Yu et al., 2014). A meta
analysis including 13 studies (n = 1672) demonstrated that
the effectiveness of Rhodiola formulations was higher compared
to control group (symptoms improvement: OR = 2.40, 95%
CI: 1.57–3.66, P < 0.0001; electrocardiography improvement:
OR = 1.48, 95% CI: 1.17–1.87, P < 0.01). In addition, the
ORs of symptomatic and electrocardiography improvement
in Rhodiola formulations versus other CHMs, versus routine
western medicine, and Rhodiola formulations plus routine
western medicine versus routine western medicine were 1.51,
2.64, 5.63, and 1.33, 3.11, 2.27, respectively (Yu et al., 2014).
These findings indicate that the formulations have a positive
effect on treating ischemic heart disease alone or in combination
with routine western medicine. In addition, there are some
formulae for angina pectoris or coronary heart disease or heart
failure which are based on syndrome differentiation (China
Association of Chinese Medicine, 2008) and are listed in
Tables 3 and 4.
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TABLE 2 | Formulae for dyslipidemia based on syndrome differentiation.
Symptom
analysis
Therapeutic
Principle
Formulae Ingredients Chinese patent drug Homo remedy
Wen Re Yun Jie Qing Re Li Shi Long-Dan-Xie-Gan Tang Longdancao, Huangqin, Sheng
Dihuang, Zhizi, Chuanmutong,
Chaihu, Danggui, Cheqianzi,
Zexie
Sang Ge Jiang Zhi Wan Jue Ming Zi, Zexie,
Shanzha Slice
Tan Shi Nei Zu Hua Tan Qi Shi Wen-Dan Tang Chenpi, Banxia, Fuling, Zhishi,
Zhuru, Baishu, Dannanxing
Zhi Ke Qing Capsule, Xue Zhi
Ling Tablet, Yue Jian Cao
Oil-emulsion
Tan Yu Jie Zhi Hua Tan Xing Yu Er-Chen-Tang and
Xue-Fu-Zhu-Yu Tang
Chenpi, Baixia, Fuling, Chaihu,
Zhishi, Chi Baishao, Sheng
Dihuang, Danggui,
Chuanqiong, Taoren, Honghua
Shan Zhuang Jiang Zhi Tablet,
Tong Mai Jiang Zhi Tablet
Pi Xu Shi Sheng Jiang Pi Li Shi Wei-Ling Tang Chenpi, Houpu, Zisuye, Fuling,
Cangshu, Zhuling, Cheqianzi,
Zexie
Jian Pi Jiang Zhi Granule, Zhi Bi
Tuo Capsule, Jiao Gu Lan Zong
Gan Tablet
Gan Shen Yin Xu Zi Bu Gan Shen Yi-Guan-Jian and
Qi-Ju-Di-Huang Wan
Danggui, Sheng Dihuang,
Gouqizi, Shanyao, Fuling,
Shanzhuyu, Zexie, Mudanpi,
Juhua, Beishashen
Jiang Zhi Ling Tablet, Yu Jin
Fang Capsule, Zhi He Shou Wu
Granule
Pi Shen Yang Xu Bu Shen Jian Pi You-Gui-Wan and
Shen-Ling-Bai-Shu San
Shu Dihuang, Gouqizi,
Duzhong, Tusizi, Fuzi, Rougui,
Shanyao, Baibiandou,
Dangshen, Fuling, Baishu
Dan Tian Jiang Zhi Wan
Formulae should be modified according to specific syndromes and clinical manifestations.
TABLE 3 | Formulae for coronary heart disease and angina pectoris based on syndrome differentiation.
Symptom analysis Therapeutic Principle Formulae Ingredients Chinese patent drug Homo remedy
Xin Xue Yu Zu Huo Xue Hua Yu, Tong
Luo Zhi Tong
Dan-Shen Yin or
Tao-Hong-Si-Wu Tang
Taoren, Danshen, Chuanqiong,
Chishao, Honghua, Sheng
Dihuang, Sharen, Tanxiang
Fu Fang Dan Shen Tablet,
Yin Xing Ye Capsule
Ren Shen San Qi San,
Huo Xue Xin Tong San
Tan Zhuo Bi Zu Hua Tan Xie Zhuo, Yi Bi
Tong Yang
Guo-Lou-Xie-Bai-Ban-Xia
Tang
Guolou, Xiebai, Fabanxia,
Fuling, Chenpi, Zhishi, Xingren
Er Chen Wan
Yin Han Ning Zhi Wen Tong Xin Yang, Kai
Bi San Jie
Guo-Lou-Xie-Bai-Gui-Zhi
Tang
Guolou, Xiebai, Guizhi, Baijiu,
Biba, Gaoliangjiang
Guan Xin Su He Wan, Su
He Xiang Wan
Qi Yin Liang Xu Yi Qi Yang Yin, Tong
Luo Zhi Tong
Sheng-Mai-San Huangqi, Dangshen, Maidong,
Wuweizi, Danshen, Honghua,
Sanqifen
Sheng Mai Yin, Tian Wang
Bu Xin Dan, Bu Xin Qi and
Yang Xin Yin Oral Solution
Xin Shen Yang Xu Wen Bu Xin Shen Jin-Kui-Shen-Qi Wan Guizhi, Danfupian, Sheng
Dihuang, Shanzhuyu, Mudanpi,
Fuling, Zexie, Sanqifen
Jin Kui Shen Qi Wan, Gui
Fu Li Zhong Wan
Formulae should be modified according to specific syndromes and clinical manifestations.
Astragalus propinquus (Leguminosae, Fabaceae)
Injection of Astragalus, also known as Huangqi, is one of
the most commonly used Chinese patent medicines for the
treatment of chronic heart failure in China as complementary
treatment to recommended Western therapies. Fu et al.
(2011) has reviewed 62 clinic trials from 1205 articles.
Although the available studies are not adequate to draw
a conclusion on the efficacy of the Huangqi injection, it
is observed to enhance myocardial contractility, improve
circulation, and protect myocardial cells with modern
pharmacological tools. For example, in an in vivo rat
model of persistent myocardial ischemia produced by
occlusion of the left anterior descending coronary artery,
pretreatment of Huangqi extract significantly decreased
the myocardial infarct size and the serum levels of lactate
dehydrogenase, creatine kinase isoform MB, and cardiac
troponin. Additionally, this treatment dramatically improved
cardiac function, as assessed by dP/dt, left ventricular developed
pressure, and left ventricular end-diastolic pressure (Ma et al.,
2013).
Cecropia pachystachya (Urticaceae)
Cecropia pachystachya, popularly called ambay, is extensively
used in herbal medicine of South America. Cecropia pachystachya
Mart growing in a temperate region produced a positive inotropic
effect on isolated rat hearts independent of beta-adrenergic effect.
In contrast, the inotropic effect was prevented by pretreatment
with high potassium media (stimulating Na-K-ATP pump),
Frontiers in Pharmacology | www.frontiersin.org 9 December 2016 | Volume 7 | Article 469
fphar-07-00469 November 29, 2016 Time: 13:50 # 10
Liu and Huang Herbs and Cardiovascular Diseases
TABLE 4 | Formulae for heart failure based on syndrome differentiation.
Symptom
analysis
Therapeutic
Principle
Formulae Ingredients Chinese patent drug Homo remedy
Xin Fei Qi Xu Bu Yi Xin Fei Bao-Yuan Tang and
Bu-Fei Tang
Dangshen, Shu Dihuang, Ziwan,
Sangbaipi, Rougui, Jiu Gancao,
Wuweizi, Fuling, Huangqi, Suan Zaoren
Bu Xin Qi Oral Solution,
Ren Shen Bao Fei Wan
Ting Li Zi, Fu Shou Cao
Qi Yin Liang Xu Yi Qi Yang Yin Wu-Wei-Zi Tang Dangshen, Maidong, Wuweizi, Guizhi,
Baishao, Sheng Dihuang, Ajiao, Jiu
Gancao, Jiu Huangqi
Sheng Mai Yin
Qi Xu Xue Yu Yi Qi Huo Xue Li Shui Bu-Yang-Huan-Wu Tang
and Wu-Ling San
Huangqi, Danggui, Chishao, Dilong,
Chuanqiong, Honghua, Taoren, Zexie,
Baishu, Zhuling, Fuling, Guizhi
Xin Tong Oral Solution,
Tong Xin Luo Capsule
Yang Xu Shui
Ting
Wen Yang Li Shui Zhen-Wu Tang Fuzi, Ganjiang, Niuqi, Chuanqiong,
Chishao, Zexie, Baishu, Zhuling, Fuling
Bu Shen Kang Le Capsule,
Xin Bao Wan
Re Tan Yong Fei Qing Fei Hua Tan, Xie
Fei Li Shui
Qing-Jin-Hua-Tan Tang Huangqin, Zhizi, Sangbaipi, Gualou,
Maidong, Chuanbeifen, Jugeng,
Gancao, Yiyiren, Dongguaren, Fuling,
Yuxingcao
Qing Fei Hua Tan Wan, Xian
Zhu Li Shui
Han Tan Zu Fei Wen Fei Hua Tan Xiao-Qing-Long Tang and
Ting-Li-Da-Zao-Xie-Fei
Tang
Mahuang, Fabanxia, Chishao,
Ganjiang, Guizhi, Wuweizi, Xixin, Tinglizi
Fu Fang Ge Qing Tablet, Ke
Chuan Capsule
Yin Jie Yang Tuo Gu Yin Hui Yang Jiu Ni Shen-Fu-Long-Mu Tang Shengshaishen, Fuzi, Ganjiang,
Maidong, Wuweizi, Longgu, Muli
Gu Shen Ding Chuan Wan,
Ren Shen Gu Ben Wan
Formulae should be modified according to specific syndromes and clinical manifestations.
indicating an inhibition of the pump by ambay (Consolini et al.,
2006).
Crataegus spp. (Rosaceae)
It has been described in previous sections (hawthorn). In isolated
perfused hearts, extracts of hawthorn have been reported to
show cardioprotective effects without affecting coronary blood
flow (Nasa et al., 1993). Simultaneously, they demonstrated
vasodilator actions and positive cardiac inotropic effect (Blesken,
1992). These results were verified in a multicenter, placebo-
controlled, double-blind study, in which WS 1442, the special
extract of hawthorn, improved cardiac function determined by
heart rate product (systolic BP × heart rate) in patients with
NYHA class II heart failure (Weikl et al., 1996). More studies are
needed to investigate the mechanisms of hawthorn to attenuate
CVDs.
Olea europaea L. (Oleaceae)
It has been described in previous sections and the main extract
from the olive leaves is oleuropein. The rabbits were subjected to
a 30 min period of regional ischemia of the heart followed by a 3 h
reperfusion. Chronic pretreatment with oleuropein reduced the
infarct size compared with the control (Andreadou et al., 2006).
In doxorubicin-induced cardiomyopathy, oleuropein effectively
improved the impaired cardiac geometry and function evidenced
by transthoracic echocardiography (Andreadou et al., 2014). In
isolated rat hearts, pretreatment with 20 µg/g oleuropein before
ischemia resulted in a significant decrease in creatine kinase and
reduced glutathione release in the perfusate. Reflow in ischemic
hearts induced oxidized glutathione release and membrane
lipid peroxidation, which were prevented by oleuropein. The
reported data demonstrated the direct cardioprotective effect of
oleuropein in the acute events that follow coronary occlusion, and
the nutritional benefit of olive oil in the prevention of coronary
heart disease (Weikl et al., 1996).
Panax notoginseng (Araliaceae)
The root of Panax notoginseng, known as Sanqi, Sanchi or Tianqi
in East Asian countries, has been identified over 80 variants
according to different substitute patterns. There are five main
saponins R1, Rb1, Rg1, Rd, and Re, constituting up to 90%
of the total Panax notoginseng used in the pharmacological
experiment. A myriad of studies demonstrate the protective effect
of notoginseng in cardiac injury. Firstly, it could significantly
improve rats’ cardiac function evidenced by left ventricular
ejection fractions, left ventricular fractional shortening, left
ventricular dimensions at end diastole and left ventricular
dimensions at end systole (Chen et al., 2011). Secondly, it
could reduce infarct size and serum level of creatine kinase
in rat models of myocardial ischemia (Yue et al., 2012; Han
et al., 2013). Thirdly, it decreased serum levels of lactate
dehydrogenase, cardiac troponin I, malondialdehyde and several
cytokines, including TNF-a, IL-1β and C-reactive protein (Han
et al., 2013). These findings suggest considerable therapeutic
potentials of notoginseng for myocardial infarction. Interestingly,
Notoginseng combined with the powdered extract of Carthamus
tinctorius, an anti-thrombus herbal medicine, or with Sals, the
active ingredient of C. tinctorius, showed stronger effects to
reduce infarct size than either drug alone (Yue et al., 2012; Han
et al., 2013; Liu et al., 2014). Thus, combination medication
remedy should be considered for CVDs treatment.
Salviae miltiorrhizae (Lamiaceae)
In addition to hypertension and hyperlipidemia, the dried root
of Salviae miltiorrhizae (Danshen) is widely used in China for
the treatment of angina pectoris and acute ischemic stroke. It
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has a range of potentially beneficial effects, including improving
microcirculation, causing coronary vasodilatation, suppressing
the formation of thromboxane, inhibiting platelet adhesion
and aggregation, and protecting against myocardial ischemia.
Danshen is widely used either alone or in combination with
other herbal ingredients for patients with coronary artery
disease or CVDs. An acute myocardial infarction model was
induced and both infarct size and echocardiographic response
were evaluated at different time after surgery. Both Sal
and tanshinone (two hypdrophilic and lipophilic compounds)
delayed the development of ischemia by decreasing infarct
size and improving systolic function post myocardial infarction
(Wang et al., 2011). However, a recent review of randomized
controlled trials of Danshen in ischemic disease published in
mainland China identified 150 trials from 1998 to 2007, but
concluded that the quality of these trials has not improved
significantly over recent years and the overall quality is still
poor (Yu et al., 2014). Since clinical studies have various
methodological problems, further high-quality randomized
controlled trials should be performed to assess the efficacy of this
herb.
MECHANISMS OF PLANT PRODUCTS IN
THE ATTENUATION OF CVDs
For over 2000 years, CVDs have been treated with numerous
herbal remedies. However, these herbal remedies have not been
well studied using modern cellular and molecular techniques.
Based on the existing investigations into mechanisms of single
herbal compounds, a summary of these studies is presented
in the following section wherein the compounds are discussed
according to their target site of activity.
Vascular Smooth Muscle Cells
Inhibiting Expression or Activity of Contractile and
Structural Proteins
The blood vessel tonicity is principally controlled by the
contraction and relaxation of VSMCs. Upon stimulation, smooth
muscle cells develop a contractile force by using the cross-
bridge cycling between the contractile proteins actins and myosin
initiated by the Ca2+-calmodulin interaction and modulated by
many other proteins. Herbal medicine that regulates proteins or
molecules in this pathway would modulate vascular contraction
or relaxation. Firstly, blocking contractile and structural proteins
may be one of the ways which natural plants could facilitate
vasodilation and vascular remodeling. It has been shown
that Tianma (the tuber of an orchid) enhances acetylcholine-
induced vasorelaxation or phenylephrine-induced contraction
in aortic rings (Feng et al., 2012). In more details, long-
term treatment with small doses of Tianma resulted in a
significant decrease of the expression levels of primary contractile
protein actin to about half the level of the controls, as well
as other cytoplasmic structural/cytoskeletal proteins, like Des,
Vcl, Pdlim1 and Map4. Secondly, phosphorylation of myosin
light chain protein is another target for herbs to determine
vascular smooth muscle contraction. A10 cells, rat smooth
muscle cells, were treated with kinds of herbs and it was
observed that four herbs, Liu-Wei-Di-Huang-Wan, Jia-Wei-
Xiao-Yao-San, Danshen and Gegen, reduced phosphorylation of
myosin light chain, suggesting that these most common herbs
may be beneficial for smooth muscle cell contractility (Lin et al.,
2015).
Regulating Expression of Extracellular Matrix
Proteins
Extracellular matrix is another target involved in vascular tone
regulation. ECM proteins such as Postn is specifically induced
upon tissue injury and could promote cellular adhesion and
movement as well as collagen fibrillogenesis. ECM glycoproteins
include Eln, Fbln5 and Prelp, being essential to maintain arterial
morphogenesis and vessel elasticity. Tianma could induce up-
regulation of ECM glycoproteins and down-regulation of ECM
proteins in vascular system, thereby regulating blood vessel
tonicity by increasing the arterial elasticity and stabilizing the
arterial structure (Feng et al., 2012).
Regulating Calcium Levels in
PKA/PKG/PKC-Dependent Way
Calcium levels in VSMCs also contribute to regulating the
vascular contraction. Tetramethylpyrazine (TMP, also known
as Ligustrazine), is a vasoactive component derived from
Ligustium Wollichii Franchat. Using dog mesenteric arterial ring
preparations, TMP not only caused a dose-dependent inhibition
of vascular contractile responses to KCl and phenylephrine
in solution with calcium, but also inhibited the responses
to phenylephrine in Ca-free medium containing 50 µM
EGTA. These results suggest that herbs may regulate vascular
contraction or relaxation by the inhibition of Ca2+ influx,
as well as the release of intracellular calcium (Kwan et al.,
1990). Consistent with it, baicalein reduced AngII-, vasopression-
and endothelin-stimulated increase in [Ca2+]i of VSMCs (Saito
et al., 1992). This effect was mimicked by a structurally
unrelated lipoxygenase inhibitor, 5,8,11-eicosatriynoic acid and
was restored by addition of 12(S)-hydroxyeicosatetraenoic acids
(Saito et al., 1992). Thus, baicalein may be representative of
the hypotensive herbs mediating Ca2+ levels which may be
partly attributed to its inhibition of lipoxygenase and consequent
decrease in biosynthesis and release of arachidonic acid-derived
vasoconstrictor products.
Alterations in large-conductance Ca2+-activated K+ channel
(BKCa channel) activity play a central role in mediating
vasoconstriction and vasodilation. Baicalin (10–100 µM) not
only concentration-dependently attenuated KCl-contracted
mesenteric arteries, but also abolished selective BKCa-channel
inhibitor IbTX, voltage-dependent Ca2+ channel activator
BayK8644, and PKC activator PMA-induced contractions at
concentrations of 100 µM (Lin et al., 2010). These findings
suggested that baicalin relaxes mesenteric artery via modulation
of the BKCa and Ca2+ channels which may be mediated
by the PKC associated pathway. Then, the BKCa-mediated
vascular contraction is further explored. The cAMP and
the cGMP pathways are major regulators of smooth muscle
contractility. By cyclic nucleotide assays, baicalin enhanced both
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cAMP and cGMP levels in mesenteric arteries. Based on the
theory that smooth muscle relaxants that increase cAMP and
cGMP have been shown to activate BKCa channels through
direct phosphorylation of the channel proteins and through
elevation of Ca2+ spark frequency, Lin et al. (2010) measured
the effects of baicalin on BKCa current by whole-cell patch
clamp electrophysiology. Baicalin was observed to enhance
BKCa currents in a concentration-dependent manner, which
were abolished by combining inhibitors of AC(SQ 22536)
and sGC(ODQ), by combining inhibitors of PKA(KT5720)
and PKG(KT5823), and PKC activator (PMA) in mesenteric
artery smooth muscle cells. These results indicate that baicalin-
induced mesenteric artery relaxations could be due to BKCa
channel activation occurs not only as a result of PKA and PKG,
but also as a result of cross-interaction with PKC (Lin et al.,
2010).
Attenuating Proliferation and Migration of VSMCs
It’s well known that stimulation of VSMCs with TNF-α
or platelet-derived growth factor-BB induced proliferation.
Camellia japonica at concentrations 50, 100, 200, and 400 µg/mL
significantly reduced the proliferation rate to 77.85, 70.12,
61.93, and 56.33% of the control (TNF-α treated without
Camellia japonica) (Park et al., 2015). Similarly, Cinnamon
extract inhibited the platelet-derived growth factor-BB-
induced proliferation of VSMCs through a G0/G1 arrest,
which down-regulated the expression of cell cycle positive
regulatory proteins by up-regulating p21 and p27 expression
(Kwon et al., 2015). The effects of Camellia japonica on
VSMCs migration was evaluated with a wound healing assay.
Camellia japonica concentration-dependently suppressed
platelet-derived growth factor-BB induced VSMCs wound
healing for 24 and 48 h after injury, indicating the migration
inhibiting effects (Park et al., 2015). In addition, baicalein and
baicalin induced anti-proliferative and anti-mitogenic effects
in VSMCs of rabbit, rat and bovine were well summarized
(Huang et al., 2005). These results provide additional
evidence for the beneficial cardiovascular effects of natural
products.
Anti-inflammation
Andrographolide is the most active and critical constituent
isolated from the leaves of Andrographis paniculata, a herbal
medicine widely used as an anti-inflammatory drugs in Asia. The
mechanisms of the inflammatory effects of andrographolide
in VSMCs were investigated by exposing VSMCs to a
proinflammatory stimulus, TNF-α. Treating TNF-α-stimulated
VSMCs with andrographolide suppressed the expression of
inducible nitric oxide synthase (NOS), JNK, Akt, and p65
phosphorylation. However, it showed no effect on either IκBα
degradation or p38 mitogen-activated protein kinase or ERK1/2
phosphorylation under these conditions. Both treatment with
LY294002, a phosphatidylinositol 3-kinase/Akt inhibitor, and
treatment with SP600125, a JNK inhibitor, markedly reversed the
andrographolide-mediated inhibition of p65 phosphorylation.
Thus, andrographolide-mediated inhibition of NF-κB activity
in TNF-α-stimulated VSMCs occurs through the JNK-Akt-p65
signaling cascade mechanism, which is independent of IκBα
degradation (Chen et al., 2014). These results collectively suggest
that therapeutic interventions using andrographolide can benefit
the treatment of vascular inflammatory diseases.
Improving Mitochondrial Function
In addition to cellular powerhouses, mitochondria are known
as critical regulators of cell death. And they are the major
cellular source of ROS which causes damage to mitochondrial
DNA in human VSMCs in a number of cardiovascular
pathologies. Thus, mitochondrial dysfunction may lead to the
impairment of various aspects of tissue functioning. It has
been known that cultured rat aortic VSMCs treated with
AngII for 24 h exhibited mitochondrial dysfunction, including
a decrease in mitochondrial oxygen consumption rates, ATP
production and mtDNA levels, as well as the disruption of
mitochondrial structural integrity (Lu et al., 2015). Together
with the mitochondrial morphological changes, these alterations
were reversed by Astragaloside IV, the major active ingredient
of Astragalus membranaceus(Fisch.) Bge. (a traditional CHM).
Moreover, treatment with Astragaloside IV also reversed the
AngII-induced increase in the production of ROS, the increase
in NADPH oxidase and xanthine oxidase activity, as well as the
decrease in mitochondrial membrane potential and manganese-
SOD activity. Furthermore, treatment with Astragaloside IV led
to an increase in the mRNA and/or protein levels of peroxisome
proliferator-activated receptor-gamma coactivator-1α (PGC-1α),
mitochondrial transcription factor A, parkin and dynamin1-like
protein1 in the VSMCs. These results indicate that Astragaloside
IV exerts beneficial effects on AngII-induced mitochondrial
dysfunction in rat VSMCs and that these effects are mediated
through the inhibition of ROS overproduction, as well as
the promotion of mitochondrial autophagy and mitochondrial
biogenesis (Lu et al., 2015).
Overall, herbal medicines discussed here do appear to
show pharmacological effects in vitro and in animal studies,
which may influence CVDs. In VSMCs, these natural plants
exert the protective effect by a series of processes (Figure 1)
which include inhibiting expression or activity of contractile
and structural proteins, modulating expression of ECM
proteins/glycoproteins, regulating calcium levels, attenuating
proliferation and migrations, alleviating inflammation, and
improving mitochondrial function.
Endothelial Cells
Activation of NO Signaling Pathway
Endothelial cells, which constitute the inner cellular lining of
blood vessels, have a key role in regulating vascular homeostasis
and function, such as vasorelaxation, vascular integrity, and
local inflammation. Endothelium-dependent vasodilation was
commonly applied to examine the endothelium function, in
which NO is a potent vasodilator and plays an important role
in regulating vascular tones. Some herbal medicine functions
by targeting at the NO producing process. In studies at the
arterial levels, both Lysimachia clethroides and gypenosides
elicit vasorelaxation which was abolished by endothelial NOS
(eNOS) or guanylyl cyclase inhibitors (Tanner et al., 1999; Lee
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FIGURE 1 | A schematic diagraph indicating the targets on which plant products/herbs act during the pathogenesis of CVDs. Plant products/herbs
demonstrate protective effect in CVDs by attenuating damage in cardiomyocytes, endothelial cells (ECs), vascular smooth muscle cells (VSMCs) and
macrophages/monocytes (M&Ms). In VSMCs, plant products/herbs show the beneficial effect by inhibiting expression or activity of contractile and structural
proteins, modulating expression of ECM proteins/glycoproteins, regulating calcium levels, attenuating proliferation and migrations, alleviating inflammation, and
improving mitochondrial function. In ECs, plant products/herbs show the beneficial effect by inhibition of inflammation, oxidative stress and apoptosis, activation of
endothelial nitric oxide synthase(NOS)-NO signaling pathway, induction of angiogenesis and suppression of endothelial permeability. In cardiomyocytes, plant
products/herbs show the beneficial effect by inhibiting cardiac hypertrophy, oxidative stress and apoptosis, opening KATP channels and increasing atrial natriuretic
peptide (ANP) secretion. In macrophages and monocytes, plant products/herbs show the beneficial effect by inhibition of inducible NOS-NO signaling pathway,
activation of estrogen receptor and nuclear receptor peroxisome proliferator activated receptor alpha (PPARα). A myriad of molecular, and cellular pathways are
favorably modulated by plant products/plants or their extracts.
et al., 2010). Sal B, a hydrophilic caffeic acid derivative of
Danshen, exerts an important regulatory function on endothelial
tissue of isolated mouse aorta by promoting NO production
through the inhibition of arginase activity (Joe et al., 2012). Fo
Shou San, an ancient herbal decoction (Chuanxiong Rhizoma
and Angelicae Sinensis Radix Danggui in a ratio of 2:3),
reversed homocysteine-induced impairment of acetylcholine-
evoked endothelium-dependent relaxation in rat aortic rings
(Bi et al., 2012). In studies at the cellular levels, gypenosides
induced a concentration-dependent increase in NO production
from cultured bovine endothelial cells (Tanner et al., 1999).
Consistent with it, magnesium tanshinoate B (another compound
purified from Danshen) or Fo Shou San, also stimulated the
release of NO and its metabolites from a human endothelial cell
line (ECV304) (O et al., 2000; Bi et al., 2012). By exploring the
mechanisms by which NO production is induced, it was observed
that the cellular NOS activities were significantly enhanced with
a concomitant increase in the levels of constitutive NOS protein
mass (O et al., 2000), phosphorylation levels of serine1177-eNOS
and serine473-Akt (Lee et al., 2010; Lu et al., 2010; Bi et al., 2012)
by a series of herbal products treatment, including magnesium
tanshinoate B, lysimachia clethroides, nordihydroguaiaretic acid
(main metabolites of creosote bush) and Fo Shou San. In
addition, Fo Shou San elevated intracellular Ca2+ levels and
eNOS phosphorylation, which was inhibited by the Ca2+ chelator
BAPTA-AM (Bi et al., 2012). These results indicate herbals may
benefit endothelial function through increased activity of Akt
kinase and eNOS, which is via a rise of intracellular Ca2+.
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Inhibition of Inflammation
Inflammation plays a crucial role in the pathophysiology of
CVDs, in which adhesion molecules, pro-inflammatory cytokines
and chemokines are involved. The anti-inflammatory effects
of Danshen and its active ingredients (Sal B, Tanshionone
IIA, Protoc et al.) were extensively investigated in traditional
Chinese medicine for therapy of CVDs. Incubation with TNFα
or ADP is widely used to induce inflammation in vitro. In
TNFα treated human coronary artery endothelial cells, Sal B
significantly inhibited the inflammation and decreased matrix
metalloproteinase-9 expression and activity by blocking the
activation of IκBα/NFκB through JNK and ERK1/2 signaling
pathways (Ma et al., 2015). In TNFα treated HUVECs, although
neither Sal B nor Tanshinone IIA inhibit the inflammation
(Stumpf et al., 2013), Danshen and Protoc attenuated expression
and/or release of CD40, VCAM-1 and ICAM-1 as well as
cytokines or chemokines (IL-6, IL-8 and MCP-1) (Stumpf et al.,
2013). In ADP-treated human platelets, pre-treatment with both
Sal B, Tanshionone IIA and Danshen significantly attenuated
platelet P-selectin expression (Stumpf et al., 2013). Gypenoside
XLIX, a dammarane-type glycoside, is a prominent component
of G. pentaphyllum. Studies demonstrate that Gypenoside
XLIX inhibits TNFα-induced VCAM-1 over expression and
hyperactivity in human endothelial cells via a PPARα-dependent
pathway (Huang et al., 2007a). These findings provide useful
insight into the rational basis of CHM in the treatment of
CVDs.
Attenuation of Oxidative Stress
It’s well known that oxidative stress contributes to endothelium
dysfunction. There are a myriad of herbs that demonstrate
effects of endothelial cell protection by different mechanisms.
For example, Sal B decreases ROS production in the aortic
rings. Since ROS easily acts with NO to produce peroxynitrite
anions, which is a potent and potentially toxic oxidant that
damages various types of biomolecules, it can be deduced that
Sal B may exert its protective function by precluding NO
consumption through adverse reactions such as peroxynitrite
formation and preserving NO bioavailability (Joe et al., 2012).
EGb 761 (Ginkgo biloba extract) suppresses oxidative stress in
a dose-dependent manner in high glucose-stimulated HUVEC.
In addition to inhibition of ROS generation and 8-OHdG
content, it attenuated oxidative DNA damage, indicating herbs
could exert endothelial protection by alleviating endothelial
DNA oxidation (He Y.T. et al., 2014). Echium amoenum extract
(a major source of anthocyanins) demonstrated antioxidant
and cytoprotective effect in H2O2-treated HUVECs. In the
endothelial injury model, pretreatment of HUVECs with the
anthocyanin-rich extract at concentrations of 100–1000 µg/ml
reduced the cell death, decreased hydro peroxide concentration,
and increased ferric reducing antioxidant power value in both
intra- and extra-cellular fluid in a concentration-dependent
manner (Safaeian et al., 2015). KRGE reduces the H2O2-induced
cell injury in HUVECs too. The inhibited effect on cell death
was blunted by HO-1 inhibitor zinc protoporphyrin. HO-1
is considered to augment the cellular defense against various
agents inducing cytotoxic injury. KRGE was observed to induce
up-regulation of HO-1 expression in HUVECs, which was
abolished by specific silencing of Nuclear factor-eythroid 2-
related factor 2 (Nrf2, a important anti-oxidant transcription
factor) expression (Yang et al., 2011). These results suggest
that Korean Red Ginseng may exert a vascular protective
effect through Nrf2-mediated HO-1 induction in human
endothelial cells. Ophiopogonin D is one of the most bioactive
components of Radix Ophiopogon japonicas. Its pretreatment
showed a series of antioxidation-related protective effects:
(1) reducing H2O2-induced lipid peroxidation and protein
carbonylation, (2) attenuating mitochondrial ROS generation
and cell apoptosis, (3) restoring cellular total antiboidative
capacity, (4) inhibiting the release of inflammatory cytokines
and blocking activation of NFκB and ERK signaling cascades,
(5) suppressing the enzymatic activity of catalase, HO-1, and
caspases (Qian et al., 2010). In general, these findings support the
protective role of herbs as an effective antioxidant in endothelial
injury.
Inhibition of Apoptosis
Although endothelial cell dysfunction occurs in many different
disease processes, caspase-dependent apoptotic cell death
induced by the extrinsic or intrinsic pathways is identified as a
common denominator. Protective effect of KRGE was examined
in a serum-deprived apoptosis model, which demonstrated that
it could prevent serum deprivation-induced HUVEC apoptosis
(Kim et al., 2013). This effect was mediated by increased Bcl-2
and Bcl-XL protein expression, PI3K/Akt-dependent Bad
phosphorylation, and eNOS/NO-mediated S-nitrosylation of
caspases. Cytosolic cytochrome c is known to play a crucial
role in the activation of the initiator caspase-9 and the effector
caspase-3. KRGE prevented subcellular redistribution of
cytochrome c from the mitochondrion into the cytosol, resulting
in suppression of the extrinsic pathway of apoptosis activation
(Kim et al., 2013). The cytoprotective property of KRGE may
be valuable for developing new pharmaceutical means that
limit endothelial cell death induced during the pathogenesis of
vascular diseases.
Inducing Angiogenesis
Angiogenesis, the formation of new blood vessels from
preexisting endothelium, is critical to a variety of processes, both
physiologically (embryonic development and wound healing)
and pathologically (malignancy and chronic inflammation). It is
a complex biologic function comprising several steps, including
sequential basement membrane degradation, endothelial cell
migration and proliferation, tube formation, inhibition of
endothelial proliferation, and the stabilization of new vessels.
Modulation of any of these steps would affect new vessel
formation. Scutellarin, a known flavone glycoside, is the primary
active component of the traditional CHM Erigeron breviscapus
(Vant.) Hand. Mazz. It has been shown to induce endothelial
cell proliferation and migration, promote capillary-like tube
formation, and significantly upregulate platelet endothelial cell
adhesion molecule-1 (Gao Z.X. et al., 2010). These results suggest
that herbal medicine promotes angiogenesis and may form a basis
for angiogenic therapy.
Frontiers in Pharmacology | www.frontiersin.org 14 December 2016 | Volume 7 | Article 469
fphar-07-00469 November 29, 2016 Time: 13:50 # 15
Liu and Huang Herbs and Cardiovascular Diseases
Suppression of Endothelial Permeability
Endothelial cell hyperpermeability is another factor implicated in
CVDs, in which the importance of tyrosine phosphorylaton and
kinase activity in oxidant-mediated loss of cell junction structures
has been demonstrated. Extract of salvia miltiorrhiza and its
major ingredients, Danshensu and Sal B inhibited TNFα-induced
endothelial permeability, evidenced by attenuated junctional
protein phosphotyrosine and prevention of beta-catenin
disassociation from the cytoskeleton (Ding and Yuan, 2007).
The mechanism of pharmacological action was further explored.
The extract, Danshensu and Sal B also repressed expression of
vascular endothelial growth factor and ERK activation in TNFα
treated HUVEC cells. In addition, it was found that the extract
attenuated the disorganization of vascular endothelial-cadherin,
which is likely due to a reduction of vascular endothelial
growth factor protein expression as a result of modulation of
the ERK signaling pathway (Ding et al., 2005). These findings
suggest that active herbal ingredients may help to attenuate
CVDs by maintaining the integrity of endothelial junction
structure.
In general, herbal medicines do show the beneficial effects in
endothelial cells. As shown in Figure 1, these natural plants exert
the protective effect by inhibition of inflammation, oxidative
stress and apoptosis, activation of eNOS-NO signaling pathway,
induction of angiogenesis and suppression of endothelial
permeability.
Cardiomyocytes
Alleviation of Cardiac Hypertrophy
Pathological cardiac hypertrophy induced by increased
sympathetic drive can subsequently lead to congestive heart
failure, which represents the major cause of morbidity
and mortality worldwide. Astragalus polysaccharide is an
active compound extracted from Chinese herb Astragalus
membranaceus for “Qi-invigorating.” In the in vitro cardiac
hypertrophic model induced by isoprenaline, Astragalus
polysaccharide treatment inhibited significant increases in cell
surface area, total protein content, protein synthesis as well as the
expression of hypertrophic markers, including ANP and B-type
natriuretic peptide. In addition, Astragalus polysaccharide
pretreatment not only alleviated the augmentation of
intracellular free calcium during cardiac hypertrophy but
also upregulated expression of calcineurin, translocation
of nuclear factor of activated T cells, cytoplasmic 3 into
nucleus and activation of calmodulin kinase II (reflected by
p-CaMKII) (Dai et al., 2014). According to this research,
Astragalus polysaccharide exerted its anti-hypertrophic action
via inhibiting Ca2+-mediated calcineurin/NFATc3 and CaMKII
signaling cascades, which provided new insights into the
application of Astragalus polysaccharide to the therapy of heart
diseases.
Chlorogenic acid is an important component of CHM,
which acts as an antioxidant scavenging free radicals and
preventing inflammation. Pre-treatment of chlorogenic acid in
the isoprenaline-induced neonatal rat myocytes, decreased the
levels of the hypertrophic markers, ANP, B-type natriuretic
peptide and β-MHC. The level of the intracellular ROS
was reduced and the nuclear translocation of NF-κB was
blocked, whereas NF-κBIA, an inhibitor of NF-κB, was
upregulated accordingly. These data reveal that chlorogenic
acid may inhibit cardiac hypertrophy by attenuating NF-κB
signaling pathway and suppressing ROS production (Li et al.,
2014).
Attenuation of Oxidative Stress
Many data have demonstrated that ROS production by
myocardial endothelial mitochondria contributes to heart disease
and oxidative stress within ventricular myocytes can also be
detrimental to the heart. In fact, much of the contractile
dysfunction and adverse myocardial remodeling, which has been
observed in a wide range of cardiomyopathies, involves oxidative
stress and eNOS uncoupling leading to a decrease in NO. There
are a series of targets at which herbal medicine act to improve
myocardial endothelial function by attenuation of oxidative
stress.
(1) Intracellular generation of ROS, including superoxide,
hydrogen peroxide and hydroxyl radicals, contributes to the
pathogenesis of cellular injury during ischemia and reperfusion
in cardiac tissues. Thus, free radical scavenging and inhibition
of oxidases will exert protective effect in cardiac injury.
Baicalein may provide such therapy by deletion of free radicals,
reducing hydroxyl radicals generation by suppressing iron-
catalyzed Fenton reaction or decreasing ROS production by
inhibiting activities of NADH-oxidase and xanthine oxidase
(Huang et al., 2005). (2) ROS may reduce NO bioactivity
through the formation of peroxynitrite and NOx. Thus it
is easy to understand the oxidized LDLs-induced endothelial
dysfunction could be restored by L-arginine and NO. The
olive products constitute a rich source of polyphenols such
as oleuropein and its derivatives, including hydroxytyrosol,
which scavenge free radicals and inhibit the chemical oxidation
of LDL. Studies have shown that treatment with high doses
of oleuropein at min 1 of reperfusion significantly reduced
levels in plasma NOx in hypercholesterolemic rabbits coupled
with reduction of infarct size in this group (Andreadou
et al., 2014). Therefore, plant products may function as a
NO donor to inhibit formation of peroxynitrite and NOx.
(3) Circulating or cellular levels of malonaldehyde, TBARS,
and protein content in carbonyls serve as Lipid peroxidation
and general oxidative stress. The decrease in these biomarkers
indicates the protective action of oleuropein, baicalein, crocetin,
Allium chinense and Astragalus against oxidative stress by
scavenging free radicals (Nasa et al., 1993; Huang et al.,
2005; Shen and Qian, 2006; Ren et al., 2010; Andreadou
et al., 2014). (4) A great amount of ROS generates from
mitochondrial electron transport inhibition, which induces
lethal oxidant damage of cardiomyocytes. Qian-Kun-Nin, a
CHM formulation was observed to significantly decreased cell
death and attenuate oxidation of DCFH in cells exposed to
the mitochondrial site III inhibitor, antimycin A, consistent
with a decrease in oxidative stress (Shao et al., 2001).
These findings indicate herbal medicine may inhibit oxidative
stress by improving mitochondrial function. (5) Myocardial
SOD, glutathione peroxidase and myocardial catalase are the
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main antioxidant enzymes, which are dramatically reduced
after ischemia and reperfusion. Pretreatment with oleuropein,
Astragalus, crocetin or cynaroside kept the SOD activity stable
in myocardial infarction models or norepinephrine induced
cardiac hypertrophy and therefore left the myocardium in an
“antioxidant state”(Nasa et al., 1993; Shen and Qian, 2006;
Sun et al., 2011; Andreadou et al., 2014). Thus, keeping
the function of antioxidant enzymes standards for another
target to inhibit oxidative stress and protect cardiac injury.
(6) Nrf2 is a master transcription factor of endogenous anti-
oxidative defense systems. Herbs such as American ginseng
could enhance this antioxidant system in rat cardiac H9C2
cells (Li et al., 2010). The antioxidant systems include
Nrf2 protein expression, Nrf2 nuclear translocation, Nrf2
transcriptional activity, direct Nrf2 binding to its target
gene promoters, and expression of a group of anti-oxidative
genes. Thus, herbs may serve as antioxidant enhancer to
provide cardioprotection against pathological cardiac injury
and remodeling. (7) Doxorubicin triggered impaired left
ventricular contractility and inflammatory and degenerative
pathology lesions, indicating a successful cardiomyopathy model.
Metabonomic analysis revealed treatment of oleuropein induced
an favorable variations in the ratio of glycolytic end products
(alamine+ lactate) to end products of lipid metabolism (acetate),
suggesting restoration of the impairment in aerobic glucose
metabolism and cardioprotection of ischemia (Andreadou et al.,
2014). This may help indentifying novel therapeutic targets
in the effect of plant products to protect the heart from
injury.
Inhibition of Apoptosis
H2O2 treatment induces both oxidative damage and apoptosis,
contributing to cardiac injury in cultured rat cardiomyocytes.
Cynaroside, a flavonoid compound, has been shown to
enhance the endogenous anti-oxidative activity, thereby
inhibiting intracellular ROS generation. It also showed the
protective effects against H2O2-induced apoptosis in H9c2
rat cardiomyoblasts. The mechanism by which cynaroside
reduced the apoptotic rate were further explored. Cynaroside
pretreatment not only moderated H2O2-induced disruption
of mitochondrial membrane potential, but also increased the
expression of anti-apoptotic protein Bcl-2 while decreased
the expression of pro-apoptotic protein Bax, and thereby
inhibited the release of apoptogenic factors (cytochrome c and
smac/Diablo) from mitochondria in H9c2 cells. Moreover,
cynaroside pretreatment showed an inhibitory effect on the
H2O2-induced increase in JNK and P53 protein expression
(Sun et al., 2011). These findings suggest that flavonoid
products prevent cardiomyocytes apoptosis in vitro by
reducing the endogenous production of ROS, maintaining
mitochondrial function, and modulating the JNK and P53
pathways.
Opening KATP Channels
Cardiac myocyte is the cell types in which KATP channels
were originally discovered. It is well established that KATP
channels are present at high density in the sarcolemma of
cardiac myocytes where they link membrane excitability
with the cellular bioenergetic state. The opening of these
channels in the heart is believed to mediate ischemic
preconditioning, a phenomenon whereby brief periods of
ischemia/reperfusion protect the heart against myocardial
infarction. Pinacidil is a potassium channel opener which
mediate preconditioning at the beginning of sustained hypoxia
by opening of sarcolemmal KATP channels (Budas et al.,
2004). Similar to it, Guanxinkang treatment benefit the heart
function by increasing mRNA and protein expression of
KATP subunits (Kir6.1, Kir6.2, SUR2A, SUR2B) in ventricular
myocytes (Chen et al., 2010). Keep in line with it, extracts of
Astragalus demonstrated its anti-apoptotic effect in H2O2-
injured cardiomyocytes only when the KATP channels were
open, whereas the protective effect was not observed when the
channels were inhibited by the KATP channel blocker (5-HD,
glibenclamide) (Nasa et al., 1993). These findings suggest
enhancing the open of KATP channel is one of the important
mechanisms by which herbs protect myocardial cells from
ischemic injury.
ANP Secretion
Atrial natriuretic peptide is secreted by the heart atrium
cells. ANP binds to a specific set of receptors and acts
to reduce the water, sodium and adipose loads on the
circulatory system, thereby reducing cardiac output and
systemic BP. Emodin, an active anthraquinone constituent
isolated from the rhubarb, was observed to increase ANP
secretion concomitantly with a decrease in atrial pulse pressure
and stroke volume in a concentration-dependent manner.
Inhibition of K+ channels with tetraethylammonium and
glibenclamide or inhibition of L-type Ca2+ channels with
nifedipine, attenuated the emodin-induced changes in ANP
secretion and atrial dynamics (Zhou et al., 2014). These findings
demonstrate that emodin may increase ANP secretion via
inhibition of L-type Ca2+ channels through an activation
of KATP channel in isolated beating rabbit atria. This study
provides a rationale for the use of herbal medicine in the
treatment of impairment of the regulation of the cardiovascular
homeostasis.
To summarize, plant products/herbal medicines do protective
cardiomyocytes from injury. As shown in Figure 1, plant
products/herbs show the beneficial effect by inhibiting cardiac
hypertrophy, oxidative stress and apoptosis, opening KATP
channels and increasing ANP secretion.
Macrophages and Monocytes
Inhibition of iNOS-Mediated NO Production
In the milieu of cardiovascular risk factors that disturb
vascular homeostasis, inflammation represents a key early
event in vascular pathology, in which monocytes activation,
adhesion to the endothelium and infiltration of macrophages
into blood vessels are thought to play important pathogenic
roles in atherosclerosis and other inflammatory CVDs. It’s
well known immune cells-derived excessive production of
NO by inducible NOS (iNOS) can cause endothelial damage,
leading to multiple vascular wall injuries. The transcriptional
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and translational regulation of iNOS in various cell types
can be induced by cytokines, growth factors, and endotoxins.
Lipopolysaccharide (LPS) stimulation has been shown to enhance
iNOS expression, NO production, and macrophage arginase
activity in RAW 264.7 macrophages, which were inhibited
by Danshen extracts and Sal B. In addition, cytoprotective
molecule HO-1 expression was upregulated by these Danshen
products too (Joe et al., 2012). SnPP is well characterized
as a potent competitive inhibitor of HO activity. Since the
iNOS expression, NO production, and TNFα production, were
completely abolished by SnPP, the anti-inflammatory effect of
Sal B in macrophages may be related to modulation of HO-
1. Hb serves as a CO scavenging compound. Preincubation of
Hb for 30 min reversed the inhibitory effect of Sal B on LPS-
induced iNOS expression, NO production and NFκB activation
in the RAW 264.7, indicating the regulatory effect of Sal B on
inflammation may be through mediating the formation of CO
(Joe et al., 2012), which shares the similar mechanism to HO-1
down-regulating proinflammatory cytokines production in LPS-
stimulated macrophages (Otterbein et al., 2000). Although the
mechanism by which HO-1 down-regulates iNOS is incompletely
clear, it may involve transcriptional inhibition through CO
formation or reduction of heme bioavailability for iNOS
synthesis.
Activation of Estrogen Receptor
Consistent with the effect of Sal B, Tanshinone IIA (another
major compound extracted from Danshen) exerts its anti-
inflammatory effects by inhibition of iNOS gene expression
and NO production, as well as inhibition of inflammatory
cytokine (IL-1β, IL-6 and TNFα) expression in RAW 264.7
cells (Fan et al., 2009). Since Tan IIA has a similar structure
to that of 17β-estradiol, the estrogenic activities was examined
in the immune cells. The Tanshinone IIA’s anti-inflammatory
effects was mimicked by estradiol and blocked by ICI182187,
the antagonist of estrogen receptor (Fan et al., 2009). In
fact, the most commonly used alternative herbal medicines
for estrogen replacement are soy, black cohosh, dong quai
and ginseng. Thus, these herbal medicines may serve as
a potential selective estrogen receptor modulator to treat
inflammation-associated CVDs without increasing the risk of
breast cancer.
Activation of PPARα
Activation of the nuclear receptor, PPARα, has been
demonstrated to modulate many aspects of lipoprotein
metabolism and inflammation both in vitro as well as in vivo.
The tissue distribution of PPARα is extensive and it may
mediate many of anti-inflammatory and anti-atherogenic effects.
Gypenoside XLIX, a dammarane-type glycoside, is one of
the prominent components in Gynostemma pentaphyllum. It
has been identified as a potent PPARα activator in HUVEC
study (Huang et al., 2007a). Tissue factor is involved in many
diseases including CVDs and hence may be an attractive target
for directed CVDs therapeutics. In human monocytic THP-1
cells transfected with promoter reporter constructs pTF-LUC,
Gyp XLIX (0–300 mM) concentration-dependently inhibited
LPS-stimulated tissue factor promoter activity, mRNA and
protein overexpression. This effect was similar to those of
Wy-14643, a potent synthetic PPARα activator, and completely
abolished in the presence of the PPARα selective antagonist
MK-886 (Huang et al., 2007b). These data indicate that Gyp
XLIX inhibits LPS-induced tissue factor overexpression and
enhancement of its activity in human THP-1 monocytic
cells via PPARα-dependent pathways, providing new insights
into the mechanism of the Chinese herbal plants in CVDs
treatment.
Overall, the natural plants/herbs do demonstrate inhibition
of inflammation in macrophages and monocytes. These
effects are achieved by inhibition of iNOS-NO signaling
pathway, which may be through activation of estrogen receptor
and nuclear receptor PPARα-dependent signaling pathways
(Figure 1).
CONCLUSION
Although many studies have been missed in this review due
to our search strategy and the limited access to some articles,
the aforementioned evidence is strongly indicative of the notion
that herbs/natural plants are the emerging medicine in the
prevention and/or treatment of CVDs. One may predict that
herbal remedies will receive even more attention in the coming
years. However, some objective limitations should be considered
based on the existing literature. Firstly, the CHM are widely
studied in China. Accordingly, many articles published on the
Chinese literature which may limit these work to be retrieved
and public to the world. In addition, a location bias cannot be
excluded since trials published in local journals are more likely
to report significant results than those published in worldwide
mainstream medical journals. Secondly, many of the clinic
trials were not well-designed and with poor methodological
quality by lacking formal inclusion/exclusion criteria, inadequate
description of the randomization procedures, too short duration
of therapy and follow-up to achieve conclusive results, et al.
Poorly designed and reported clinic trails usually exaggerate
the treatment effects which will misled decision making in
clinic. Thirdly, compounds contained in one herb, even in an
extract of one herb are very complicated. Thus, it is a very
tough work to clarify the mechanism of plant products/herb for
treating CVDs and interaction with other medicines (including
western medicines). Fourthly, many herbal medicine remedies
used today have not undergone careful scientific assessment and
there still lack preclinical study on the side effects, toxic effects
and major drug-to-drug interactions in record. Even though,
natural plants/herbs are germs of medicine and should deserve
more attention and application. Therefore, to develop new agents
with effectiveness and safety from traditional Chinese medicine
is a promising way for prevention and treatment of patients with
CVDs. However, clinic study criteria should be documented to
standardize evaluation of plants/herbs. In addition, international
collaboration may be encouraged, promoted and financed from
the governments in order to improve the overall research
quality.
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